Moderna Expands mRNA Capability Through $85m OriCiro Acquisition

 
• By Lisa Takagi

Moderna has made its first-ever acquisition with the $85m purchase of OriCiro Genomics, a Japanese bioventure with DNA synthesis and amplification technology. The deal is expected to contribute to Moderna’s capabilities in both manufacturing and R&D.

DNA amplification and synthesis technology of OriCiro has already attracted more than $10m financing in Japan
OriCiro's DNA amplification and synthesis platform had already attracted more than $10m in financing • Source: Shutterstock

More from Deals

More from Business